Published in Vaccine Weekly, July 23rd, 2003
"A single inoculation of herpes simplex virus type-1 (HSV-1) amplicon vectors encoding human immunodeficiency virus type-1 gp120 (HSV:gp120) results in robust, specific immune responses to gp120," explained Xiuqing Wang and colleagues at the University of Rochester Medical Center in Rochester, New York and the University of California at Davis.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly